Savage L J, Simpson D D
Am J Drug Alcohol Abuse. 1978;5(1):23-38. doi: 10.3109/00952997809029258.
The present study was based on follow-up data on 1,409 persons interviewed 4 to 6 years after admission to drug treatments in the Drug Abuse Reporting Program (DARP). The admissions to DARP occurred in 1969-1971, and for most persons the follow-up data included 3 or more years after termination of DARP treatment. The focus of this study was on illicit drug use of former DARP clients, taking into account if and when they reentered drug treatment after termination of DARP treatment. The results showed that a significant drop in opioid and nonopioid (but not marijuana) drug use generally occurred upon entry into other, post-DARP treatments, and that these beneficial effects of treatment tended to continue beyond the end of treatment. Overall, 42% of the sample had no further drug treatment during the first 3 years after DARP, and almost half (42%) of this group used no opioid or nonopioid drugs at all during this time. Comparisons between DARP treatment groups also indicated that therapeutic community clients had the lowest rate of return to post-DARP treatments.
本研究基于药物滥用报告项目（DARP）中1409名接受药物治疗4至6年后接受访谈者的随访数据。DARP的入院时间为1969 - 1971年，对于大多数人来说，随访数据包括DARP治疗结束后的3年或更长时间。本研究的重点是DARP前服务对象的非法药物使用情况，并考虑他们在DARP治疗结束后是否以及何时重新接受药物治疗。结果显示，在进入DARP后的其他治疗时，阿片类药物和非阿片类药物（但不包括大麻）的使用普遍显著下降，并且这些治疗的有益效果在治疗结束后仍趋于持续。总体而言，42%的样本在DARP后的前3年没有接受进一步的药物治疗，并且该组中几乎一半（42%）的人在此期间根本没有使用阿片类或非阿片类药物。DARP治疗组之间的比较还表明，治疗社区的服务对象返回DARP后治疗的比例最低。
